Bundle 4 (IC 2027)
If you are seeing this page, then you are not signed in or have not yet enrolled in the City of Hope Self-Directed Intensive Course in Genomic Cancer Risk Assessment.
To return the course homepage, click the button below.
If you need assistance, contact us at [email protected].
Key:
Complete
Next
Failed
Available
Locked
Hereditary Breast/Ovarian Cancer Syndromes
Open to view video. | 43 minutes
Open to view video. | 43 minutes
Recognize features of high-penetrance hereditary breast/breast and ovarian cancer syndromes
Describe the established and emerging genetic etiologies of breast and ovarian cancer
Review the impact of founder mutations associated with BRCA 1 & 2 hereditary breast and ovarian cancer
Examine the benefits and limitations of genetic analysis and risk management for hereditary breast/breast ovarian cancer
Hereditary Breast/Ovarian Cancer Syndromes: Moderate Risk Genes - Part 1
Open to view video. | 27 minutes
Open to view video. | 27 minutes
Describe the concept of "penetrance" and how it relates to high & moderate risk cancer susceptibility genes
Counsel a patient about moderate and low penetrance cancer susceptibility genes found on routine clinical testing
Understand that moderate and low penetrance cancer susceptibility genes may not track with the family history of cancer
Recognize that findings on germline panels are not always actionable
Hereditary Breast/Ovarian Cancer Syndromes: Moderate Risk Genes - Part 2
Open to view video. | 48 minutes
Open to view video. | 48 minutes
Describe the concept of ‘penetrance’ and how it relates to high & moderate risk cancer susceptibility genes
Counsel a patient about moderate and low penetrance cancer susceptibility genes found on routine clinical testing
Understand that moderate and low penetrance cancer susceptibility genes may not track with the family history of cancer.
Recognize that findings on germline panels are not always actionable.
Breast Cancer Risk Assessment
Open to view video. | 58 minutes
Open to view video. | 58 minutes
Apply mutation probability and empiric risk assessment models for breast cancer
Formulate an evaluation & management plan
ICSD 2026 - Bundle 4 Quiz
17 Questions | Unlimited attempts | 25/31 points to pass
17 Questions | Unlimited attempts | 25/31 points to pass
Select the appropriate response for each question. Correct responses will display after a passing score of 80% (25/31) is reached. Please retake the quiz until you pass.
Bundle 4 Distance Learning Evaluation
16 Questions
16 Questions
Please respond to the statements in this evaluation as they relate to your experiences with this week's distance learning modules. This survey will take less than 3 minutes to complete.